Tag : Chronic Lymphocytic Leukemia

Latest News

Irutinib-based therapy provides superior clinical outcomes in majority of CLL patients

Newsemia
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) today announced results from an extended follow-up analysis of patients in its randomized Phase 3 clinical trial, E1912. Source...
Latest News

Rutgers researcher receives $600,000 grant to study chronic lymphocytic leukemia

Newsemia
Rutgers Cancer Institute of New Jersey researcher Hossein Khiabanian, PhD, has received a $600,000 Translational Award from the V Foundation for Cancer Research to study...
Latest News

Combination treatment effective as front-line therapy for select chronic lymphocytic leukemia patients

Newsemia
Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia, have been shown to be effective when given together for high-risk and older patients...
Latest News

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Newsemia
Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva®...
Latest News

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

Newsemia
AbbVie, a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a...
Latest News

FDA expands label for VENCLEXTA to include information about patients with previously-treated CLL

Newsemia
AbbVie, a research-based global biopharmaceutical company, today announced the U.S. Food and Drug Administration has expanded the label for VENCLEXTA® in combination with rituximab to...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy